[go: up one dir, main page]

HK1125840A1 - Use of selected lactic acid bacteria for reducing infantile colic - Google Patents

Use of selected lactic acid bacteria for reducing infantile colic

Info

Publication number
HK1125840A1
HK1125840A1 HK09104187.6A HK09104187A HK1125840A1 HK 1125840 A1 HK1125840 A1 HK 1125840A1 HK 09104187 A HK09104187 A HK 09104187A HK 1125840 A1 HK1125840 A1 HK 1125840A1
Authority
HK
Hong Kong
Prior art keywords
lactic acid
acid bacteria
selected lactic
infantile colic
reducing
Prior art date
Application number
HK09104187.6A
Other languages
English (en)
Inventor
Eamonn Connolly
Bo Moellstam
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38790468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1125840(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of HK1125840A1 publication Critical patent/HK1125840A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK09104187.6A 2006-06-05 2009-05-06 Use of selected lactic acid bacteria for reducing infantile colic HK1125840A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/446,628 US7374924B2 (en) 2006-06-05 2006-06-05 Use of selected lactic acid bacteria for reducing infantile colic
PCT/SE2007/050371 WO2007142596A1 (fr) 2006-06-05 2007-05-30 Utilisation d'une bactérie d'acide lactique choisie pour réduire les coliques infantiles

Publications (1)

Publication Number Publication Date
HK1125840A1 true HK1125840A1 (en) 2009-08-21

Family

ID=38790468

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09104187.6A HK1125840A1 (en) 2006-06-05 2009-05-06 Use of selected lactic acid bacteria for reducing infantile colic

Country Status (21)

Country Link
US (3) US7374924B2 (fr)
EP (1) EP2040722B1 (fr)
JP (3) JP4520531B2 (fr)
KR (2) KR101308865B1 (fr)
CN (2) CN101374533B (fr)
AU (2) AU2007200434B2 (fr)
BR (1) BRPI0710944B8 (fr)
CA (1) CA2650546C (fr)
DK (1) DK2040722T3 (fr)
GE (1) GEP20125480B (fr)
HK (1) HK1125840A1 (fr)
HU (1) HUE026416T2 (fr)
IL (1) IL194779A0 (fr)
MX (1) MX2008014869A (fr)
MY (1) MY162708A (fr)
NZ (2) NZ596788A (fr)
RU (1) RU2435844C2 (fr)
SI (1) SI2040722T1 (fr)
UA (1) UA93911C2 (fr)
WO (1) WO2007142596A1 (fr)
ZA (1) ZA200809531B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
ES2658837T3 (es) * 2008-03-14 2018-03-12 Nestec S.A. Mezcla simbiótica
AU2014221272B2 (en) * 2008-11-03 2016-01-21 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
US9034314B2 (en) * 2008-11-03 2015-05-19 Nestec S.A. Nutritional composition comprising probiotics and improving sleep patterns
US20110104327A1 (en) * 2009-04-23 2011-05-05 Bacterfield International S.A. Probiotic pet food
US20120121562A1 (en) 2009-07-31 2012-05-17 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
NL2004101C2 (en) * 2010-01-15 2011-07-18 Friesland Brands Bv Ruminant il-10 and use in modulating immune response.
IT1401460B1 (it) * 2010-06-11 2013-07-26 Probiotical Spa "ceppi di batteri probiotici produttori di vitamina b12"
KR101706100B1 (ko) * 2011-12-15 2017-02-15 삼성전자주식회사 성형한계선도 획득용 시험장치
EP2609813A1 (fr) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 pour le développement du système nerveux entérique
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
CA3176938A1 (fr) * 2013-08-09 2015-02-12 Ab-Biotics, S.A. Probiotiques pour des cas de pleurs infantils excessifs
UA120846C2 (uk) * 2014-01-23 2020-02-25 Біогайа Аб Вибір штаму молочнокислих бактерій, який модулює гастроінтестинальний біль
CA2960337C (fr) * 2014-10-29 2022-04-05 Nestec S.A. Utilisation de l. reuteri pour la recuperation d'une dysbiose du microbiote dans la phase precoce
EP3294308A4 (fr) 2015-05-14 2019-03-06 University of Puerto Rico Procédé de restauration du microbiote de nouveau-nés
JP6529835B2 (ja) * 2015-06-23 2019-06-12 株式会社フィス 樹状細胞活性化剤
CN105219683B (zh) * 2015-11-04 2018-03-13 广东省农业科学院动物科学研究所 一株具有益生特征的罗伊氏乳杆菌菌株及其应用
WO2017117142A1 (fr) 2015-12-28 2017-07-06 New York University Dispositif et procédé de restauration du microbiote chez les nouveau-nés
CN106497840B (zh) * 2016-11-07 2019-06-21 江南大学 一种定向分离免疫调节性肠道乳杆菌的方法
CA3099255A1 (fr) * 2018-07-24 2020-01-30 Biogaia Ab Selection et utilisation de bacteries favorisant la production de melatonine pour reduire la colique infantile
JP2021531015A (ja) * 2018-07-24 2021-11-18 バイオガイア・エイビーBiogaia AB アデノシンレベルを増加させることができる細菌株を使用する治療法
PL3773648T3 (pl) 2019-04-17 2024-08-26 Biogaia Ab Terapeutyczne mikropęcherzyki bakterii probiotycznych
CN117925484B (zh) * 2024-03-19 2024-07-09 山东中科嘉亿生物工程有限公司 一株改善睡眠呼吸暂停的罗伊氏粘液乳杆菌jylb-101及其产品和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518696A (en) 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
US5413960A (en) 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5458875A (en) 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
CA2213434C (fr) 1995-12-21 2008-12-09 Abbott Laboratories Utilisation de lactobacillus reuteri dans l'inhibition de la cryptosporidiose chez les mammiferes
US5837238A (en) 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US5800813A (en) 1996-11-12 1998-09-01 Biogaia Biologics Ab Treatment of cryptosporidium infections
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
EP1034788A1 (fr) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Souches de bacteries lactiques capables de prevenir la diarrhée
EP1344458A1 (fr) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Système d'administration de composés probiotiques
EP1384483A1 (fr) * 2002-07-23 2004-01-28 Nestec S.A. Microorganismes probiotiques pour le traitement du syndrome du colon irritabile par l'amélioration de la fonction neuro-musculaire de l'intestin
US7105336B2 (en) 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
ES2329020T3 (es) * 2002-10-18 2009-11-20 Biogaia Ab Procedimiento para potenciar la funcion inmunitaria en mamiferos usando cepas de lactobacillus reuteri.
US20040208863A1 (en) 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
US20040185032A1 (en) 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
NZ544726A (en) * 2003-06-23 2009-05-31 Nestec Sa Infant or follow-on formula
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US8603460B2 (en) * 2006-06-05 2013-12-10 Brogaia AB Method of making a Lactobacillus reuteri with increased acid tolerance

Also Published As

Publication number Publication date
CA2650546A1 (fr) 2007-12-13
RU2008147883A (ru) 2010-07-20
US9340840B2 (en) 2016-05-17
JP2009539371A (ja) 2009-11-19
AU2007200434B2 (en) 2010-09-02
AU2010202976A1 (en) 2010-08-05
AU2007200434A1 (en) 2007-12-20
AU2010202976B2 (en) 2012-12-20
BRPI0710944A2 (pt) 2017-04-18
HUE026416T2 (en) 2016-07-28
EP2040722A1 (fr) 2009-04-01
NZ572359A (en) 2011-12-22
JP4520531B2 (ja) 2010-08-04
CN102488717B (zh) 2018-03-27
US20120121564A1 (en) 2012-05-17
US9057112B2 (en) 2015-06-16
NZ596788A (en) 2013-03-28
EP2040722A4 (fr) 2010-06-02
SI2040722T1 (sl) 2016-02-29
JP2010202654A (ja) 2010-09-16
MX2008014869A (es) 2008-12-05
KR20090015903A (ko) 2009-02-12
KR101308865B1 (ko) 2013-09-17
CA2650546C (fr) 2011-08-02
MY162708A (en) 2017-07-14
GEP20125480B (en) 2012-04-25
CN101374533B (zh) 2012-02-01
UA93911C2 (ru) 2011-03-25
ZA200809531B (en) 2010-03-31
US20070280913A1 (en) 2007-12-06
KR20100080565A (ko) 2010-07-08
BRPI0710944B8 (pt) 2021-05-25
BRPI0710944B1 (pt) 2020-12-29
WO2007142596A1 (fr) 2007-12-13
EP2040722B1 (fr) 2015-11-11
JP2013173749A (ja) 2013-09-05
IL194779A0 (en) 2009-08-03
DK2040722T3 (en) 2016-02-01
CN101374533A (zh) 2009-02-25
CN102488717A (zh) 2012-06-13
US20080131414A1 (en) 2008-06-05
RU2435844C2 (ru) 2011-12-10
KR101030661B1 (ko) 2011-04-20
JP5865283B2 (ja) 2016-02-17
US7374924B2 (en) 2008-05-20

Similar Documents

Publication Publication Date Title
HK1125840A1 (en) Use of selected lactic acid bacteria for reducing infantile colic
EP2136824A4 (fr) Utilisation de bactérie d'acide lactique sélectionnée pour réduire l'athérosclérose
IL258730A (en) Preparations and methods for the treatment of microbial disorders
IL194958A0 (en) Use of arylcarboxylic acid biphenylamides for seed treatment
EP1988155A4 (fr) Bactérie lactique capable de produire de l'acide -aminobutyrique
HK1155481A1 (en) Lactic acid bacterium having effect of lowering blood uric acid level
EP2032131A4 (fr) Procédé de traitement
ZA201005798B (en) Treatment of microbial infections
EP2273989A4 (fr) Polythérapie pour le traitement des infections bactériennes
SI2029155T1 (sl) Izboljšano zdravljenje multiplega mieloma
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
GB0610746D0 (en) Method of treatment
ZA201100616B (en) Treatment of antibiotic-resistant bacteria infection
ZA200808363B (en) Compounds and methods for diagnosis and treatment of leishmaniasis
ZA200807357B (en) Inhibitors of PAI-1 for treatment of muscular conditions
GB0818805D0 (en) Preparation, use of preparation for treatment, and method of treatment of harmful intestinal coliform bacteria
PL1998747T3 (pl) Zastosowanie fermentowanego produktu mlecznego do pielęgnacji skóry
IL194066A0 (en) Therapeutic composition for treatment of tinnitus
GB0723100D0 (en) Treatment of HFnEF
EP1994117A4 (fr) Neutralisation de spores bactériennes
ZA201204249B (en) Treatment of microbial infections
GB0618060D0 (en) Treatment of polyamides
IL193025A0 (en) Crystalline forms of ciclesonide
GB2442705B (en) Inactivation of gram-positive bacteria
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones